Biomarkers for Prostate Cancer
Prostate cancer biomarkers refine decision-making across screening, biopsy, surveillance, staging, and advanced disease. This presentation covers PHI, 4KscoreⓇ, SelectMDx, ExoDx™ Prostate, Confirm mdx, PCA3, MiPS, and genomic assays, including ProlarisⓇ, Oncotype DX Prostate ScoreⓇ, DecipherⓇ, and ArteraAI, with discussion of PSMA PET and advanced disease markers such as AR-V7 and BRCA alterations.
Read More